Young James Emmett Insider Trades

Insider Trading History

Track insider trading activity for Young James Emmett. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MedTech Acquisition
MedTech Acquisition MTAC
Chief Financial Officer
Holding Value $563k 49,663 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$149k 13,175 shares
$11.34
$11.34
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $564k 49,663 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 13,175 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $164k 49,663 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$68.2k 13,175 shares
$5.18
$3.30
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $10.8k 49,663 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.87k 13,175 shares
$0.22
$0.22
MedTech Acquisition
MedTech Acquisition MTAC
Chief Financial Officer
Holding Value $414k 36,488 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 14,762 shares
$11.34
$11.34
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $414k 36,488 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$168k 14,762 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $7.95k 36,488 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22k 14,762 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $120k 36,488 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84k 14,762 shares
$5.69
$3.30
MedTech Acquisition
MedTech Acquisition MTAC
Chief Financial Officer
Holding Value $340k 30,000 shares
Last Trade
Feb 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$68k 6,000 shares
$11.34
$11.34
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $6.54k 30,000 shares
Last Trade
Feb 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.31k 6,000 shares
$0.22
$0.22
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $341k 30,000 shares
Last Trade
Feb 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$68.1k 6,000 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $99k 30,000 shares
Last Trade
Feb 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.9k 6,000 shares
$5.65
$3.30
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $248k 75,000 shares
Last Trade
Jan 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 75,000 shares
$5.30
$3.30
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Chief Financial Officer
Holding Value $79.2k 24,000 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$130k 24,000 shares
$5.40
$3.30
MedTech Acquisition
MedTech Acquisition MTAC
Chief Financial Officer
Holding Value $851k 75,000 shares
Last Trade
Jan 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$851k 75,000 shares
$11.34
$11.34
MedTech Acquisition
MedTech Acquisition MTAC
Chief Financial Officer
Holding Value $272k 24,000 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$272k 24,000 shares
$11.34
$11.34
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $16.4k 75,000 shares
Last Trade
Jan 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.4k 75,000 shares
$0.22
$0.22
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Chief Financial Officer
Holding Value $5.23k 24,000 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.23k 24,000 shares
$0.22
$0.22
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $851k 75,000 shares
Last Trade
Jan 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$851k 75,000 shares
$11.35
$11.35
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Chief Financial Officer
Holding Value $272k 24,000 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$272k 24,000 shares
$11.35
$11.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up